Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $5.6000 (-3.45%) ($5.6000 - $5.9000) on Thu. Oct. 27, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.14% (three month average) | RSI | 32 | Latest Price | $5.6000(-3.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.9% a day on average for past five trading days. | Weekly Trend | CGEN declines -3.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) EWG(4%) TBT(4%) URA(4%) XRT(3%) EWI(2%) | Factors Impacting CGEN price | CGEN will decline at least -1.07% in a week (0% probabilities). VCSH(-8%) VCIT(-8%) USO(-8%) TIP(-7%) TAN(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.07% (StdDev 2.14%) | Hourly BBV | 0 () | Intraday Trend | -4.3% | | | |
|
1 - 5 Day Possible Target | $-0.53(-109.46%) | Resistance Level | $6.06 | 5 Day Moving Average | $5.82(-3.78%) | 10 Day Moving Average | $5.92(-5.41%) | 20 Day Moving Average | $6.06(-7.59%) | To recent high | -24.4% | To recent low | 0% | Market Cap | $463m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |